(Q21260315)

ORCID Public Data File 2021

19 August 2022

8

Lars Tanum

Lars

Tanum

1 reference

19 August 2022

5

Maija

Konstenius

Maija Konstenius

1 reference

19 August 2022

1

Jørgen G

Bramness

Jørgen G Bramness

1 reference

1018899510

19 August 2022

Øystein Hoel Gundersen

2

Øystein Hoel

Gundersen

Øystein Hoel Gundersen

1 reference

19 August 2022

4

Eline Borger

Rognli

Eline Borger Rognli

1 reference

19 August 2022

6

Else-Marie

Løberg

Else-Marie Løberg

1 reference

19 August 2022

7

Sigrid

Medhus

Sigrid Medhus

1 reference

19 August 2022

9

Johan

Franck

Johan Franck

1 reference

1018899510

Creative Commons Attribution 2.0 Generic

19 August 2022

language of work or name

English

0 references

publication date

December 2012

0 references

5 December 2012

4 references

19 March 2019

7 November 2019

30 May 2020

14 August 2023

5 references

19 March 2019

7 November 2019

30 May 2020

14 August 2023

12

0 references

issue

1

0 references

page(s)

221

0 references

copyright license

4 references

19 March 2019

7 November 2019

30 May 2020

on focus list of Wikimedia project

14 August 2023

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Methamphetamine-associated psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Cannabis and psychosis/schizophrenia: human studies

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Treatment for amphetamine psychosis

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder

19 March 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

19 March 2017

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

A neurobiological basis for substance abuse comorbidity in schizophrenia

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context.

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Long-term outcomes in methamphetamine psychosis patients after first hospitalisation

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Ventral and dorsal striatal dopamine efflux and behavior in rats with simple vs. co-morbid histories of cocaine sensitization and neonatal ventral hippocampal lesions

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Methamphetamine and paranoia: the methamphetamine experience questionnaire

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Amphetamine psychosis: a model for studying the onset and course of psychosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Prevalence of nonmedical methamphetamine use in the United States

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The epidemiology of methamphetamine use and harm in Australia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992-2007.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The rise of methamphetamine in Southeast and East Asia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Substance-induced psychosis: a diagnostic conundrum

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Cannabinoids and psychosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Studies of amphetamine or methamphetamine psychosis in Japan: relation of methamphetamine psychosis to schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The psychology and neurobiology of addiction: an incentive-sensitization view

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Stimulant psychosis: symptom profile and acute clinical course

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Adverse effects of stimulant drugs in a community sample of drug users.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Provocative tests with psychostimulant drugs in schizophrenia

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Methamphetamine use in rural Midwesterners

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The expert consensus guideline series. Treatment of behavioral emergencies 2005.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Amphetamine: effects on catecholamine systems and behavior

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Amphetamine psychosis and psychotic symptoms

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Methamphetamine use and schizophrenia: a population-based cohort study in California

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Precipitating factors in spontaneous recurrence of methamphetamine psychosis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Long-lasting hypersensitivity to methamphetamine following amygdaloid kindling in cats: the relationship between limbic epilepsy and the psychotic state.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

The phenomenology of experimentally induced amphetamine psychosis--preliminary observations

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Methylphenidate Hallucinosis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Ipecac syrup--correct dosage.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Methamphetamine abuse: a perfect storm of complications

30 May 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Clinical course and outcomes of methamphetamine-dependent adults with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

The prevalence of psychotic symptoms among methamphetamine users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Amphetamine availability and admissions for psychosis in New South Wales, 2001-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Impulsivity and methamphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

A rating scale for evaluation of the clinical course and symptomatology in amphetamine psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Psychotic symptoms in methamphetamine psychotic in-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Longitudinal clinical course following pharmacological treatment of methamphetamine psychosis which persists after long-term abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Factors for Susceptibility to Episode Recurrence in Spontaneous Recurrence of Methamphetamine Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Susceptibility to Episode Recurrence in Spontaneous Recurrence of Methamphetamine Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Human response to repeated low-dose d-amphetamine: evidence for behavioral enhancement and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Neurotoxic effects of amphetamine plus L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Neuromechanism of developing methamphetamine psychosis: a neuroimaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

The risk of psychotic symptoms associated with recreational methamphetamine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Findings of preserved implicit attention in methamphetamine dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Amphetamine poisoning. Effectiveness of chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Six-month outcomes for patients who switched to olanzapine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Testing hypotheses about the relationship between cannabis use and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

Methamphetamine-Associated Psychosis: A Model for Biomarker Discovery in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-221

A comparison of symptoms and drug use between patients with methamphetamine associated psychoses and patients diagnosed with schizophrenia in two acute psychiatric wards

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

An emerging problem: methamphetamine abuse among treatment seeking youth

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Substance abuse in hospitalized psychiatric patients

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Psychosocial and behavioral correlates of depressed mood among female methamphetamine users.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Psychosis associated with prescribed dexamphetamine use.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Adderall-induced psychosis in an adolescent.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Six months follow-up of patients with methamphetamine psychosis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3554477

Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA

29 November 2018

1 reference

12 December 2020

Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia

1 reference

12 December 2020

Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study

1 reference

12 December 2020

Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting

1 reference

12 December 2020

Acute psychosis associated with therapeutic use of dextroamphetamine

1 reference

12 December 2020

The experimental reproduction of amphetamine psychosis

1 reference

12 December 2020

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

1 reference

12 December 2020

Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history

1 reference

12 December 2020

A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-12-221

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-12-221

1 reference

9 September 2019

1 reference

1 reference

PubMed publication ID

23216941

1 reference